Latest news

Daily Snap - 13. October 2025

Daily Snap - 13. October 2025

Joachim Eeckhout
BMS pushes into in vivo CAR-T with $1.5B Orbital Therapeutics takeover

BMS pushes into in vivo CAR-T with $1.5B Orbital Therapeutics takeover

Eduardo Longoria
Evommune files for IPO to back oral immune drugs for skin conditions

Evommune files for IPO to back oral immune drugs for skin conditions

Eduardo Longoria
Daily Snap - 10. October 2025

Daily Snap - 10. October 2025

Joachim Eeckhout
AviadoBio expands into eye diseases with $413M UgeneX deal

AviadoBio expands into eye diseases with $413M UgeneX deal

Eduardo Longoria
Novo Nordisk buys Akero for $5.2B to lead the MASH drug race

Novo Nordisk buys Akero for $5.2B to lead the MASH drug race

Eduardo Longoria
Daily Snap - 9. October 2025

Daily Snap - 9. October 2025

Joachim Eeckhout
Arthrosi secures $153M series E to fund late-stage gout drug development

Arthrosi secures $153M series E to fund late-stage gout drug development

Eduardo Longoria
Sanofi’s $110M radioligand hits tumor target in pivotal phase 2 study

Sanofi’s $110M radioligand hits tumor target in pivotal phase 2 study

Eduardo Longoria
Daily Snap - 8. October 2025

Daily Snap - 8. October 2025

Joachim Eeckhout
MapLight targets $262M IPO to back schizophrenia drug rivaling Cobenfy

MapLight targets $262M IPO to back schizophrenia drug rivaling Cobenfy

Eduardo Longoria
AstraZeneca’s hypertension strategy gains momentum with baxdrostat’s success

AstraZeneca’s hypertension strategy gains momentum with baxdrostat’s success

Eduardo Longoria
FirstBack
345678910
Next Last